Search

Your search keyword '"Moeller, B"' showing total 341 results

Search Constraints

Start Over You searched for: Author "Moeller, B" Remove constraint Author: "Moeller, B"
341 results on '"Moeller, B"'

Search Results

2. POS0204 EFFECTIVENESS OF TNF INHIBITION IN VERY EARLY AXIAL SPONDYLOARTHRITIS (LESS THAN ONE YEAR OF AXIAL SYMPTOM DURATION): RESULTS FROM A LARGE NATIONAL OBSERVATIONAL COHORT

3. POS0259 DOES BIOLOGIC DMARD RETENTION IN AXIAL PSORIATIC ARTHRITIS DEPEND ON THE MODE OF ACTION? COMPARISON OF TNF, IL-17, AND IL-23 INHIBITORS IN A LARGE OBSERVATION COHORT

4. OP0034 DIFFERENTIAL JOINT-LEVEL RESPONSES TO TNF INHIBITORS IN PSORIATIC ARTHRITIS: A COLLABORATIVE EUROPEAN OBSERVATIONAL COHORT STUDY

5. Combined electrical transport and capacitance spectroscopy of a ${\mathrm{MoS_2-LiNbO_3}}$ field effect transistor

6. Characterization of the Cyclic Material Behavior of AlSi10Mg and Inconel® 718 Produced by SLM

10. Kleene algebra with domain

12. POS1548 ENTHESITIS OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS INITIATING A TUMOUR NECROSIS FACTOR INHIBITOR IN A REAL-WORLD SETTING: DATA FROM THE EuroSpA COLLABORATION NETWORK

13. POS0374 HOW WELL DO EULAR/ASAS-EULAR AND NATIONAL TREATMENT RECOMMENDATIONS FOR PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS ALIGN? IS IT TIME FOR AN UPDATE OF NATIONAL TREATMENT RECOMMENDATIONS?

15. POS0918 VALIDATION OF A MODIFIED NEW YORK CRITERIA RETIC E-TOOL FOR INCREASING SCORING PROFICIENCY OF RADIOGRAPHS OF THE SACROILIAC JOINTS IN AXIAL SPONDYLOARTHRITIS

16. POS0547 RISK OF SARS-COV-2 INFECTION FOLLOWING THREE DOSES OF BNT162B2 OR MRNA-1273 IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES

22. SEX DIFFERENCES IN EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS; RESULTS FROM THIRTEEN COUNTRIES IN THE EUROSPA RESEARCH COLLABORATION NETWORK

25. OP0175 TYPE OF mRNA COVID-19 VACCINE AND TREATMENT INFLUENCE ANTIBODY KINETICS IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES

26. POS0077 SEX DIFFERENCES IN EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS; RESULTS FROM THIRTEEN COUNTRIES IN THE EuroSpA RESEARCH COLLABORATION NETWORK

29. Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland

35. SECULAR TRENDS IN BASELINE CHARACTERISTICS, TREATMENT RETENTION AND RESPONSE RATES IN 17453 BIONAIVE PSORIATIC ARTHRITIS PATIENTS INITIATING TNFI - RESULTS FROM THE EUROSPA COLLABORATION

36. OP0220 SECULAR TRENDS IN BASELINE CHARACTERISTICS, TREATMENT RETENTION AND RESPONSE RATES IN 17453 BIONAÏVE PSORIATIC ARTHRITIS PATIENTS INITIATING TNFI – RESULTS FROM THE EUROSPA COLLABORATION

38. AB0531 THERAPIES FOR PERIPHERAL JOINT INVOLVEMENT IN PSORIATIC ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW

39. Therapies for peripheral joint involvement in psoriatic arthritis: a systematic literaure review

41. Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland

42. Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland

49. OP0075 SPINAL RADIOGRAPHIC PROGRESSION IN AXIAL SPONDYLOARTHRITIS AND THE IMPACT OF CLASSIFICATION AS NONRADIOGRAPHIC VERSUS RADIOGRAPHIC DISEASE

50. SAT0430 SECUKINUMAB EFFECTIVENESS IN 1543 PATIENTS WITH PSORIATIC ARTHRITIS TREATED IN ROUTINE CLINICAL PRACTICE IN 13 EUROPEAN COUNTRIES IN THE EuroSpA RESEARCH COLLABORATION NETWORK

Catalog

Books, media, physical & digital resources